Published by Josh White on 23rd February 2026
(Sharecast News) - Novacyt announced on Monday that it has conditionally agreed to acquire Southern Cross Diagnostics for an initial cash consideration of AUD 8.5m (£4.45m), as the molecular diagnostics group looked to expand its footprint in the fast-growing Australian market and accelerate its path to profitability.